202 related articles for article (PubMed ID: 37573318)
21. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
22. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
[TBL] [Abstract][Full Text] [Related]
23. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
[TBL] [Abstract][Full Text] [Related]
24. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
Zhang L; Tu Y; He W; Peng Y; Qiu Z
Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
[TBL] [Abstract][Full Text] [Related]
25. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
26. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.
Liu J; Ding X; Tang J; Cao Y; Hu P; Zhou F; Shan X; Cai X; Chen Q; Ling N; Zhang B; Bi Y; Chen K; Ren H; Huang A; He TC; Tang N
PLoS One; 2011; 6(11):e27496. PubMed ID: 22110662
[TBL] [Abstract][Full Text] [Related]
28. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
29. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
[TBL] [Abstract][Full Text] [Related]
30. [Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells
Wang J; Cao C; Zeng Q; Dong Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):679-684. PubMed ID: 31270046
[TBL] [Abstract][Full Text] [Related]
31. Baicalin inhibits hepatocellular carcinoma cell growth and metastasis by suppressing ROCK1 signaling.
Sun J; Yang X; Sun H; Huang S; An H; Xu W; Chen W; Zhao W; He C; Zhong X; Li T; Liu Y; Wen B; Du Q; He S
Phytother Res; 2023 Sep; 37(9):4117-4132. PubMed ID: 37246830
[TBL] [Abstract][Full Text] [Related]
32. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
[TBL] [Abstract][Full Text] [Related]
33. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway.
Pan J; Fan Z; Wang Z; Dai Q; Xiang Z; Yuan F; Yan M; Zhu Z; Liu B; Li C
J Exp Clin Cancer Res; 2019 Feb; 38(1):52. PubMed ID: 30717785
[TBL] [Abstract][Full Text] [Related]
34. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
Li C; Yang J; Lei S; Wang W
Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
[TBL] [Abstract][Full Text] [Related]
35. CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway.
Yang L; Tan W; Wei Y; Xie Z; Li W; Ma X; Wang Q; Li H; Zhang Z; Shang C; Chen Y
Cell Death Dis; 2022 May; 13(5):464. PubMed ID: 35581180
[TBL] [Abstract][Full Text] [Related]
36. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
[TBL] [Abstract][Full Text] [Related]
37. The Akt/GSK3β/β-catenin signaling regulated by ZCCHC14 is responsible for accelerating the proliferation of hepatocellular carcinoma.
Cui Y; Zhang J; Chen C; Luo J; Yan H; Jiang W
J BUON; 2021; 26(5):1958-1963. PubMed ID: 34761605
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma.
Li J; Tuo D; Guo G; Gan J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15763-15779. PubMed ID: 37668796
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.
Lv J; Ma L; Chen XL; Huang XH; Wang Q
J Huazhong Univ Sci Technolog Med Sci; 2014 Jun; 34(3):363-369. PubMed ID: 24939300
[TBL] [Abstract][Full Text] [Related]
40. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
